Antares Pharma appoints Fred M. Powel as CFO
Most recently, Mr. Powell served as Vice President and Chief Financial Officer for Celator Pharmaceuticals.
Prior to joining Celator, Mr. Powell was the chief financial officer of OraPharma until its acquisition by Valeant Pharmaceuticals in June, 2012.
He was also chief financial officer of BMP Sunstone Corporation. He also held senior finance and administration positions at Eximias Pharmaceutical Corporation, Innaphase Corporation and ERT.
Mr. Powell began his career with KPMG Peat Marwick and is a graduate of Penn State University.